The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Sparked by Concerns Over Growth of Clinics Offering Unapproved Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
For full access to this article login to GEN Select now.
European Bioindustry Upbeat in the Long Term
Pundits Cast Optimistic Predictions about the Future of the Biotechnology Business
- A popular feature of “BioPartnering Europe” (BPE), which took place in London late last year, is the Bioforecaster review, which looks at the life and health sciences sector across Europe and tries to predict what will happen over the next six months. This year in particular, everyone was keen ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.